Updated September 2026Floors, no membershipNucore Health review
Three figures, all floors, with no membership fee and health-account eligibility stated.
The verdict
Nucore Health publishes as low as $179 a month for compounded semaglutide, read August 2026. The oral is $209 and tirzepatide is $269. All three are floors. No membership fee applies.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Injection
- From $179/mo
- Oral
- From $209/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Nucore Health sells semaglutide as an injection and an oral, plus tirzepatide by injection. All three figures use as-low-as wording.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages state prices and eligibility. The clinician is not described.
The fee position is clear and the price position is not. There is no membership. What raises a floor is unstated.
What happens when the dose goes up?
Nothing is published about dose. As low as covers the bottom of a range whose top is not given. Both unknowns sit on the same figure.
What the price includes
Six months at $179 is $1,074 at best. The oral is $1,254 and tirzepatide $1,614, also at best. FSA and HSA eligibility is stated, which affects tax treatment rather than price.
What it claims, and what it cites
All three lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: No membership fee, stated in writing
- Strength: FSA and HSA eligibility published
- Strength: An oral option priced separately
- Limitation: All three figures are floors
- Limitation: What raises them is not published
- Limitation: No milligram dose stated
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Nucore Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader using a health account who will ask what their own figure is.
- Wrong for
- A reader who needs a settled monthly price.
How Nucore Health compares
| Seller | Who it suits | Go |
|---|---|---|
| NuBloom | Readers who want the top dose priced before starting the lowest | See NuBloom → |
| NuDay Rx | Readers wanting an oral semaglutide at the injection price | See NuDay Rx → |
 Obu Health | Readers who value a site that agrees with itself | See Obu Health → |
More GLP-1 telehealth sellers reviews: Ozari HealthPallas HealthPepHaūsPeterMDPlexusDxPlushCare
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is there a membership fee?
- No. The site states there is none.
- Is $179 a rate?
- No. It is an as-low-as figure and the top of the range is not published.
- Can I use an HSA?
- FSA and HSA eligibility is stated on the injection and tirzepatide lines.
- Is Nucore Health expensive compared with other GLP-1 telehealth sellers?
- Nucore Health publishes a starting figure of $179/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Nucore Health right at the median. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.